We are live on
!
Find out more
TWMP
Taylor Wealth Management Partners Portfolio holdings
AUM
$176M
1-Year Est. Return
14.65%
This Fund
S&P 500
This Quarter
Est. Return
+4.35%
1 Year Est. Return
-14.65%
3 Year Est. Return
+62.03%
5 Year Est. Return
+168.63%
10 Year Est. Return
–
AUM
$274M
AUM Growth
+$14.1M
(+5.4%)
Cap. Flow
+$8.5M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
39.31%
Holding
71
New
7
Increased
23
Reduced
38
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$6.71M |
| 2 |
Pultegroup
PHM
|
+$5.62M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$5.29M |
| 4 |
Truist Financial
TFC
|
+$5.08M |
| 5 |
Western Digital
WDC
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$5.39M |
| 2 |
Microsoft
MSFT
|
+$3.92M |
| 3 |
CryoPort
CYRX
|
+$3.72M |
| 4 |
Pfizer
PFE
|
+$2.9M |
| 5 |
Willdan Group
WLDN
|
+$1.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.49% |
| 2 | Healthcare | 16.7% |
| 3 | Financials | 15.4% |
| 4 | Industrials | 13.36% |
| 5 | Consumer Discretionary | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRTX
51
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $573K | 0.21% |
64,982
+229
| +0.4% | +$2.51K |
|
52
Krystal Biotech
KRYS
$9.66B
| $494K | 0.18% |
6,415
+637
| +11% | +$46.3K |
|
53
Gilead Sciences
GILD
$165B
| $340K | 0.12% |
5,263
+1,556
| +42% | +$100K |
|
54
Vertex Pharmaceuticals
VRTX
$126B
| $299K | 0.11% |
1,393
+30
| +2% | +$6.59K |
|
|
RCM
55
DELISTED
R1 RCM Inc. Common Stock
RCM
| $289K | 0.11% |
11,705
+680
| +6% | +$18K |
|
56
Stryker
SYK
$130B
| $287K | 0.1% |
1,178
+225
| +24% | +$54K |
|
57
Thermo Fisher Scientific
TMO
$220B
| $278K | 0.1% |
609
-28
| -4% | -$13.4K |
|
58
KALA BIO
KALA
$14.5M
| $255K | 0.09% |
15
+5
| +50% | +$97.6K |
|
59
BiomX
PHGE
$1.85M
| $234K | 0.09% |
173
-31
| -15% | -$41.9K |
|
60
Zimmer Biomet
ZBH
$18.4B
| $233K | 0.09% |
+1,497
| New | +$232K |
|
61
Viatris
VTRS
$19.1B
| $183K | 0.07% |
13,131
-3,002
| -19% | -$48.9K |
|
62
Colony Bankcorp
CBAN
$467M
| $158K | 0.06% |
10,151
| – | – |
|
|
PHGE.WS
63
DELISTED
BiomX Inc. Warrants to purchase one-half of a share of Common Stock
PHGE.WS
| $29K | 0.01% |
43,928
-75
| -0.2% | -$55 |
|
Similar funds
LPWM
ED
PC
ACM
HWIS
LWM
EW
TWM
Taylor Wealth Management Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Taylor Wealth Management Partners held 71 positions worth $274M, up 5.4% from $260M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Taylor Wealth Management Partners deployed $8.5M of net new capital in Q1 2021, opening 7 new positions and adding to 23 existing holdings. Its largest new stake was Elevance Health: 20,873 shares worth $7.49M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was PayPal, an estimated $5.39M trimmed.
- Taylor Wealth Management Partners's largest Q1 2021 buy was Elevance Health: 20,873 shares worth $7.49M.
- Taylor Wealth Management Partners added most to Truist Financial in Q1 2021, an estimated $5.08M increase.
- Taylor Wealth Management Partners's biggest Q1 2021 reduction was PayPal, cutting an estimated $5.39M.
- Taylor Wealth Management Partners's ten largest holdings make up 39% of its $274M portfolio in Q1 2021.
- Taylor Wealth Management Partners opened 7 new positions and closed 0 in Q1 2021.
- Taylor Wealth Management Partners's portfolio value rose 5.4% quarter-over-quarter to $274M.
Based on Taylor Wealth Management Partners's 13F filing for Q1 2021, filed 21 Apr 2021.